Where is Kala headquartered?

Kala is located in Watertown, MA.

Who invested in Kala?

Kala has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Kala?

Kala closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

kalarx.com

Kala

Kala is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of ocular diseases.

Business Model:

Revenue: $5.7M

Employees: 51-200

Geographic Data

Address: 490 Arsenal Way

City: Watertown

State: MA

Zip: 02472

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$16M

Raised Total:

$506M

Social

Facebook

Twitter

Crunchbase

Metrics

17,455Website Global Rank

7,333,682Website Monthly Traffic

Twitter Followers

Description

Kala is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of ocular diseases.

Contact Phone:
+17819965252

Contact Email:

IPO Details

Kala went public on 7/20/2017 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/20/2017

IPO Valuation:
$349M

Ticker Symbol:
KALA

IPO Price:
$15/share

Amount Raised:
$90M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
4/2016	Series C	8	$68M	Vivo Capital Polaris Partners CAM Capital OrbiMed Longitude Capital Lux Capital Wellington Management RA Capital Management Longitude Capital Vivo Capital Polaris Partners CAM Capital OrbiMed Longitude Capital Lux Capital Wellington Management RA Capital Management Longitude Capital
11/2021	Post-IPO Equity		$16.1M
11/2022	Post-IPO Equity		$31M
11/2022	Private Placement		$31M
5/2021	Post-IPO Debt	1	$125M	Oxford Finance LLC Oxford Finance LLC Oxford Finance LLC Oxford Finance LLC
4/2014	Series B		$0	Ysios Capital AbbVie Biotech Ventures Crown Venture Fund Lux Capital Polaris Ventures Third Rock Ventures Ysios Capital AbbVie Biotech Ventures Crown Venture Fund Lux Capital Polaris Ventures Third Rock Ventures
3/2012	Private Equity Round	4	$7.2M	Third Rock Ventures Polaris Partners Lux Capital Lighthouse Capital Partners
10/2018	Post-IPO Equity	1	$110M	Athyrium Capital Management LP Athyrium Capital Management LP Athyrium Capital Management LP Athyrium Capital Management LP
2/2013	Series A		$0	Crown Venture Fund Lux Capital Polaris Ventures Third Rock Ventures Crown Venture Fund Lux Capital Polaris Ventures Third Rock Ventures
7/2017	IPO		$103.5M
12/2009	Series A		$2M
8/2015	Venture Round		$7M
11/2010	Venture Round		$3M
4/2020	Post-IPO Equity		$134M
4/2014	Series B	6	$22.5M	Ysios Capital Ysios Capital
2/2013	Series A	4	$11.5M	Crown Venture Fund Crown Venture Fund

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details